| Literature DB >> 27729008 |
Feng Huang1, Peng Yu1, Yin Yuan1, Qiaowei Li1, Fan Lin1, Zhonghai Gao2, Falin Chen3, Pengli Zhu4.
Abstract
BACKGROUND: Many studies showed an association between dietary salt intake, blood pressure and increased CVD risk. The potential reason may be related to vascular structural and functional changes, through alterations in endothelial function. The central retinal arteriolar equivalent and urinary albumin reflected vascular endothelial dysfunction in different part of the body. The urinary sodium-creatinine ratio of causal urine specimens could represent the 24-h urinary sodium intake to estimate sodium intake.Entities:
Keywords: Blood pressure; Central retinal arteriolar equivalent; Sodium excretion; Urinary albumin-creatinine ratio
Mesh:
Substances:
Year: 2016 PMID: 27729008 PMCID: PMC5057275 DOI: 10.1186/s12872-016-0369-1
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Characteristics of the 2456 study participants
| Characteristics | Participants | Q1( | Q2( | Q3( | Q4( |
|
|---|---|---|---|---|---|---|
| Age, y | 51.4 ± 12.7 | 50.7 ± 12.8 | 51.5 ± 12.3 | 53.0 ± 12.1 | 57.4 ± 12.8 | <0.001 |
| male/ female | 914/1542 | 299/315 | 232/382 | 231/383 | 152/462 | <0.001 |
| BMI, kg · m2 | ||||||
| <24 | 1049 (57.4 %) | 370(60.3 %) | 363(59.1 %) | 354(57.7 %) | 326(53.1 %) | <0.001 |
| 24–28 | 806(38.8 %) | 197(32.0 %) | 196(31.9 %) | 198(32.2 %) | 211(34.4 %) | <0.001 |
| >28 | 241 (9.8 %) | 47(7.7 %) | 55(9.0 %) | 62(10.1 %) | 77(12.5 %) | <0.001 |
| SBP, mmHg | 129.9 ± 22.9 | 126.8 ± 22.0 | 126.9 ± 21.3 | 129.6 ± 21.7 | 136.4 ± 25.2 | <0.001 |
| DBP, mmHg | 79.2 ± 11.9 | 77.7 ± 11.8 | 77.9 ± 11.5 | 79.7 ± 11.5 | 81.4 ± 12.4 | <0.001 |
| Blood pressure classification | ||||||
| Normotension | 1505 (61.3 %) | 424(69.1 %) | 421(68.6 %) | 374(60.9 %) | 286(46.6 %) | <0.001 |
| Hypertension | 951 (38.7 %) | 190(30.9 %) | 193(31.4 %) | 240(39.1 %) | 328(53.4 %) | <0.001 |
| eGFR, ml · min−1 · 1.73−1 · m−2 | 106.4 ± 30.2 | 107.5 ± 29.2 | 106.7 ± 31.7 | 106.4 ± 30.7 | 103.8 ± 30.7 | >0.05 |
| Serum glucose, mmol/L | 5.23 ± 1.15 | 5.31 ± 1.13 | 5.16 ± 1.13 | 5.16 ± 0.98 | 5.27 ± 1.41 | >0.05 |
| Triglyceride, mmol/L | 0.8(0.6,1.2) | 0.8(0.6,1.3) | 0.8(0.6,1.2) | 0.8(0.6,1.2) | 0.8(0.6,1.3) | >0.05 |
| Total cholesterol, mmol/L | 4.97 ± 0.99 | 4.97 ± 1.02 | 4.93 ± 0.96 | 4.92 ± 1.03 | 5.02 ± 1.04 | >0.05 |
| HDL- cholesterol, mmol/L | 1.22 ± 0.34 | 1.20 ± 0.32 | 1.21 ± 0.34 | 1.23 ± 0.34 | 1.22 ± 0.34 | >0.05 |
| LDL-cholesterol, mmol/L | 2.73 ± 0.86 | 2.71 ± 0.90 | 2.74 ± 0.83 | 2.70 ± 0.87 | 2.79 ± 0.91 | >0.05 |
| Sodium excretion, g | 10.95 ± 2.72 | 8.2 ± 2.5 | 15.1 ± 1.9 | 22.3 ± 2.5 | 40.6 ± 14.5 | <0.001 |
| UACR, mg/g | 10.6(4.7,23.9) | 6.2(2.9,12.5) | 8.6(4.0,17.7) | 11.9(5.8,22.8) | 22.5(10.3,43.0) | <0.001 |
| CRAE, um | 133.3 ± 11.1 | 134.7 ± 10.9 | 133.4 ± 11.2 | 133.4 ± 10.9 | 131.5 ± 11.2 | <0.001 |
continuous variables were reported as mean ± deviation (SD) or median (upper and lower quartile), and categorical variables as percentages (%)
Q1 group: Sodium excretion <9.04 g. Q2 group: Sodium excretion was 9.04 g-10.73 g. Q3 group: Sodium excretion was 10.74 g-12.61 g. Q4 group: Sodium excretion >12.61 g. BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, HDL-cholesterol: high-density lipoprotein cholesterol, LDL-cholesterol: low-density lipoprotein protein cholesterol, eGFR: estimated glomerular filtration rate, UACR: urinary albumin-creatinine ratio, CEAE: central retinal artery diameter, 1 mmHg: 0.133 kPa
Relationship between age, sex, blood pressure, body mass index, and sodium excretion
| Item | Cases | Sodium excretion (g) |
|---|---|---|
| Age (years old) | ||
| 30–40 | 384 | 10.3 ± 2.4 |
| 40–50 | 689 | 10.7 ± 2.5 |
| 50–60 | 620 | 11.2 ± 2.7 |
| 60–70 | 482 | 11.3 ± 2.9 |
| ≥70 | 281 | 11.3 ± 3.1 |
|
| <0.001 | |
| Sex | ||
| Male | 914 | 11.0 ± 2.7 |
| Female | 1542 | 10.9 ± 2.7 |
|
| 0.73 | |
| SBP (mmHg) | ||
| Q1 80–112 | 546 | 10.4 ± 2.3 |
| Q2 113–126 | 670 | 10.5 ± 2.4 |
| Q3 127–142 | 568 | 11.2 ± 2.7 |
| Q4 143–230 | 672 | 11.7 ± 3.1 |
|
| <0.001 | |
| DBP (mmHg) | ||
| Q1 50–69 | 484 | 10.3 ± 2.5 |
| Q2 70–77 | 597 | 10.6 ± 2.5 |
| Q3 78–85 | 686 | 11.0 ± 2.6 |
| Q4 86–124 | 689 | 11.7 ± 3.0 |
|
| <0.001 | |
| BMI (kg · m−2) | ||
| 15.7–21.3 | 614 | 10.2 ± 2.5 |
| 15.8–23.4 | 611 | 10.7 ± 2.6 |
| 23.5–25.6 | 617 | 11.2 ± 2.6 |
| 25.7–39.6 | 614 | 11.8 ± 2.9 |
|
| <0.001 | |
| Triglyceride (mmol L−1) | ||
| < 1.7 | 2169 | 10.9 ± 2.7 |
| ≥ 1.7 | 287 | 11.1 ± 2.9 |
|
| 0.53 | |
| Total cholesterol (mmol · L−1) | ||
| < 5.2 | 1565 | 10.9 ± 2.6 |
| ≥ 5.2 | 891 | 11.1 ± 2.9 |
|
| 0.02 | |
| LDL-cholesterol (mmol · L−1) | ||
| < 3.4 | 1981 | 10.9 ± 2.6 |
| ≥ 3.4 | 475 | 11.3 ± 3.0 |
|
| <0.001 | |
| Serum glucose (mmol · L−1) | ||
| < 6.0 | 2156 | 10.9 ± 2.7 |
| ≥ 6.0 | 300 | 11.0 ± 2.9 |
|
| 0.88 | |
aTrend analysis
The UACR, CRAE, and BaPWV in sodium excretion quartiles
| Item | Q1 ( | Q2 ( | Q3 ( | Q4 ( |
|
|---|---|---|---|---|---|
| UACR (mg.g−1)a | 1.79 ± 1.23 | 2.17 ± 1.25 | 2.41 ± 1.21 | 2.95 ± 1.21 | <0.001 |
| CRAE (um) | 134.77 ± 11.17 | 133.57 ± 11.49 | 133.52 ± 11.49 | 131.24 ± 10.83 | <0.001 |
aThe UACR values after logarithmic transformation. UACR: urinary albumin-creatinine ratio, CEAE: central retinal artery diameter
Logistic regression analysis demonstrating the relationship of UACR/CRAE and Sodium excretion
| Sodium excretion group | UACR | CRAE | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unadjusted OR (95 % CI) |
|
| Adjusted OR (95 % CI) |
|
| Unadjusted OR (95 % CI) |
|
| Adjusted OR (95 % CI) |
|
| |
| Q1 | 1.00 (control) | —— | <0.001 | 1.00 (control) | —— | <0.001 | 1.00 (control) | —— | <0.001 | 1.00 (control) | —— | <0.001 |
| Q2 | 1.78 (1.22–2.58) | 0.003 | 1.75 (1.18–2.59) | 0.005 | 1.28 (0.98–1.67) | 0.068 | 1.22 (0.92–1.61) | 0.176 | ||||
| Q3 | 2.24 (1.56–3.22) | <0.001 | 2.01 (1.37–2.95) | <0.001 | 1.18 (0.91–1.55) | 0.219 | 1.11 (0.83–1.47) | 0.489 | ||||
| Q4 | 7.10 (5.08–9.92) | <0.001 | 5.62 (3.93–8.06) | <0.001 | 1.61 (1.24–2.09) | <0.001 | 1.36 (1.01–1.82) | 0.041 | ||||
Adjusted variables included age, sex, BMI, CRAE, Triglyceride, Total cholesterol, HDL-cholesterol, LDL-cholesterol, Serum glucose, eGFR, SBP, and DBP
aTrend analysis